Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

Status Completed

Clinical Trial Summary

To report preliminary results on safety and tolerability of intravitreal injection of Ranibizumab (Lucentis) combined with Transpupillary Thermotherapy (TTT)+ Indocyanine Green (ICG)-based photodynamic therapy (PDT) in the treatment of choroidal melanoma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00680225
Study type	Interventional
Source	New England Retina Associates
Contact
Status	Completed
Phase	Phase 3
Start date	September 2007
Completion date	July 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00750399` - Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma	Phase 1
Recruiting	`NCT03941379` - A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Completed	`NCT02875652` - Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)	N/A
Completed	`NCT00765921` - Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma	Phase 1
Completed	`NCT00351728` - Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone	N/A
Completed	`NCT01460810` - Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma	N/A
Completed	`NCT01251978` - Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)	Phase 2
Completed	`NCT00344799` - Cytogenetic Study of Ocular Melanoma
Completed	`NCT01253759` - Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma	Phase 4
Completed	`NCT03052127` - Study in Subjects With Small Primary Choroidal Melanoma	Phase 1/Phase 2
Active, not recruiting	`NCT00111046` - Pain Relief - Tramadol Versus Ibuprofen	Phase 1/Phase 2
Recruiting	`NCT06007690` - A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma	Phase 3
Active, not recruiting	`NCT04417530` - Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma	Phase 2
Terminated	`NCT05266430` - Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)